第14回アジア汎太平洋小児栄養消化器肝臓学会議, TRAVEL AWARD,Effect of Gut Microbiota on Intestinal Epithelial Tight Junction Permeability in Juvenile Rats with Food AllergyTulyeu J Kumagai H Jimbo E Yokoyama K Imagawa T Hirose Y Yamagata
Journal of gastroenterology and hepatology 39(2) 312-318 2023年12月
BACKGROUND AND AIM: Even with increasing numbers of biologic agents available for management of ulcerative colitis (UC), infliximab (IFX) retains an important place in treatment of pediatric patients with this disease. As few reports have addresse...
Takayama T Muguruma N Igarashi M Ohsumi S Oka S Kakuta F Kubo Y Kumagai H Sasaki M Sugai T Sugano K Takeda Y Doyama H Banno K Fukahori S Furukawa Y Horimatsu T Ishikawa H Iwama T Okazaki Y Saito Y Matsuura N Mutoh M Tomita N Akiyama T Yamamoto T Ishida H Nakayama Y
Kiri Koshu Kazuhiro Muramatsu Tomomi Maru Yoshie Kurokawa Yoshitaka Mizobe Hirokazu Yamagishi Daisuke Matsubara Koji Yokoyama Eriko Jimbo Hideki Kumagai Yukihiro Sanada Yasunaru Sakuma Noriyoshi Fukushima Aya Narita Takanori Yamagata Hitoshi Osaka
Brain & development 45(9) 517-522 2023年7月
BACKGROUND: Niemann-Pick disease type C (NPC) is an autosomal recessive inherited and neurodegenerative disorder. Approximately 10% of NPC patients have acute liver failure and sometimes need liver transplantation (LT), and 7% reportedly develop i...
Journal of gastroenterology and hepatology 38(7) 1107-1115 2023年7月
BACKGROUND: Vedolizumab (VDZ) is a humanized monoclonal antibody that binds to α4β7 integrin expressed in T-lymphocytes and is gut selective. Few studies have evaluated the safety and efficacy of VDZ in pediatric ulcerative colitis (UC) patients, ...
自治医科大学
医学部